Over the past year there were no insider purchases at Mangoceuticals, Inc.. Two insiders sold roughly $174,000 instead.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
Big money check: 18 institutions held MGRX as of Q2 2026, and funds were split between buying and selling. No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Dec 17, 2025 | JOHNSTON EUGENE M | CFO | Sell | 3,333 | $1.17 | $4K | SEC |
| Dec 11, 2025 | JOHNSTON EUGENE M | CFO | Sell | 5,000 | $1.20 | $6K | SEC |
| Dec 9, 2025 | JOHNSTON EUGENE M | CFO | Sell | 10,000 | $1.13 | $11K | SEC |
| Nov 26, 2025 | Hamilton Alex P. | Director | Sell | 125,000 | $1.22 | $152K | SEC |
| Jun 27, 2024 | Hamilton Alex P. | Director | Sell | 16,574 | $0.31 | $5K | SEC |
| Jun 27, 2024 | Hamilton Alex P. | Director | Sell | 108,426 | $0.32 | $35K | SEC |
| May 2, 2023 | Tiger Cub Trust | CEO | Buy | 275,000 | $1.00 | $275K | SEC |
In the last 12 months Mangoceuticals, Inc. insiders made open-market purchases worth about $0 and sales worth about $174,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in MGRX was filed on 2025-12-17.
18 investment managers reported holding MGRX in SEC Form 13F filings for Q2 2026.
No congressional trades in MGRX were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).